Lapiplasty

Lapiplasty is a patented surgical procedure that corrects bunions by realigning the metatarsal bone in all three planes. Insurance providers such as Aetna, UnitedHealthcare, and Blue Cross Blue Shield classify Lapiplasty under bunion correction surgeries with specific CPT codes like 28297.

Insurers require documentation of failed conservative treatments–such as orthotics or NSAIDs–for at least three to six months before approving Lapiplasty coverage. Medicare covers Lapiplasty when deemed medically necessary due to severe pain or functional impairment unresponsive to non-surgical care.

Most policies view Lapiplasty as “medically necessary” only when patients report difficulty walking, persistent swelling, or progressive deformity after other treatments fail. Out-of-pocket costs for Lapiplasty range from $3,500 to $7,000 if insurance denies coverage, according to claims data from 2022.

Some insurers–like Cigna and Humana–consider Lapiplasty investigational and deny reimbursement without robust clinical evidence of superiority over traditional osteotomies. Preauthorization is required by nearly all major carriers before performing Lapiplasty; denials frequently cite lack of imaging proof (e.g. weight-bearing radiographs) documenting advanced hallux valgus.

Appeals succeed more often when podiatrists submit operative reports showing prior non-surgical management attempts with physical therapy and shoe modifications, according to the Insurance Information Database. Postoperative complications relevant to coverage determinations include hardware irritation (9% incidence) and metatarsalgia (reported in 6% of cases).

Coding errors–such as misclassifying Lapiplasty under general foot surgery CPT codes–lead to higher denial rates; always use the designated code for triplanar bunion correction.